-
Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer
en-cphi.cn
March 07, 2019
The second Phase 3 study initiation announcement made during the International HPV Awareness Day
-
Hands Don't Spread HPV, Study Finds
drugs
February 18, 2019
Human papillomavirus (HPV) is easily transmitted during sex, but it is unlikely to be passed by the hands, Canadian researchers report....
-
Inovio’s Synthetic DNA Vaccine Shows Promise in Treating HPV-Related Head & Neck Cancer
americanpharmaceuticalreview
January 25, 2019
Inovio Pharmaceuticals announced a second patient with HPV-related head and neck cancer treated with INO-3112 (now called MEDI0457) in a Phase 1 trial achieved ....
-
Messages for Increasing Parental Confidence in HPV Vaccine ID'd
drugs
January 23, 2019
Providing information on the benefits of vaccination, including cancer prevention, and avoiding expressing urgency to vaccinate can increase parent confidence in human papillomavirus (HPV) vaccination....
-
HPV vaccines continue to dominate cancer vaccines landscape
pharmaceutical-technology
January 08, 2019
Cancer vaccines are a type of immunotherapy used to either treat existing cancer or prevent the development of cancer.
-
HPV Ups Cervical Cancer Risk, Even With No Cellular Signs
drugs
December 25, 2018
The presence of certain high-risk human papillomavirus (HPV) types predicts future risk for high-grade cervical cancer even among women with no cellular indications of cancer at baseline, according to a study published online Dec. 10 in Cancer....
-
Merck's Gardasil turns in $1B in monster Q3
fiercepharma
December 04, 2018
Merck’s Gardasil has been propelling the pharma giant’s vaccine unit in recent quarters, and that doesn't look like it'll be changing.
-
US FDA approves HPV vaccine for men and women aged 27-45
pharmafile
November 20, 2018
The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman between the ages of 27 and 45. Previously the vaccine
-
Inflection Biosciences Announces Research Collaboration with MD Anderson
pharmafocusasia
November 05, 2018
Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced that it has entered into a research...
-
Radiation/cisplatin established as standard of care for HPV+ oral cancer
europeanpharmaceuticalreview
October 29, 2018
Results of a Phae III trial showed that cetuximab with radiation was associated with inferior overall survival and progression-free survival…